PP173—Cytisin Amidophosphate Shows Hepatoprotective Effect

2013

Full text Open access: Hybrid Metadata (CSL-JSON)
DOI 10.1016/j.clinthera.2013.07.210
Data confidence 70 medium
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

The problem of effective and rational treatment of no viral hepatitis is still actual. During several last years, the screening of the bioactivity of the list of semi-synthetic derivatives of alkaloid cytisine was held in our laboratories. The result was the synthesis of O,O dimethyl-N-cytinizylphosphate (cytisin amidophosphate). Hepatoprotective properties were noted on the several models of acute and chronic hepatitis. Purpose: to study the efficacy and safety of cytisin amidophosphate under the name of Cytaphat in patients with toxic hepatopathy.